NCT00141219View on ClinicalTrials.gov

Pregabalin Peripheral Neuropathic Pain Study

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Diabetic NeuropathiesNeuralgia
Interventions
DRUG

pregabalin

150-600mg/day, BID

DRUG

Placebo

Placebo

Trial Locations (10)

463-802

Pfizer Investigational Site, Sungnam-si

443-721

Pfizer Investigational Site, Suwon

602-739

Pfizer Investigational Site, Busan

705-715

Pfizer Investigational Site, Daegu

501-757

Pfizer Investigational Site, Gwangju

110-744

Pfizer Investigational Site, Seoul

120-752

Pfizer Investigational Site, Seoul

130-702

Pfizer Investigational Site, Seoul

135-720

Pfizer Investigational Site, Seoul

137-701

Pfizer Investigational Site, Seoul

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00141219 - Pregabalin Peripheral Neuropathic Pain Study | Biotech Hunter | Biotech Hunter